Needham Turns Bullish on Biogen Stock, Call Traders Respond

Call volume is running at double what is typically seen at this point

Deputy Editor
Sep 23, 2021 at 10:30 AM
facebook X logo linkedin


The shares of Biogen Inc (NASDAQ:BIIB) are up 2.7% at $297 this morning, following a bull note from Needham. The analyst in question initiated coverage of the stock with a "buy" rating and a $400 price target, citing Alzheimer drug Aduhelm as a big seller in the long term as it predicted more than $6 billion in sales across the globe.

Needham joins a split brokerage bunch, though there is reason to believe that its bull note could be just the beginning for Biogen stock. Heading into today, 13 considered BIIB a "buy" or better, compared to 14 calling it a "hold." Meanwhile, the equity's 12-month consensus price target of $416.37 is a 39% premium to current levels.

Call activity is ramping up in response to the analyst attention. So far today, Biogen's normally quiet options pits have seen 1,755 calls exchange hands, which is double the intraday average, and more than three times the amount of puts across the tape. The most popular contract is the 9/24 300-strike call, where positions are being opened.

That bullish sentiment has been the norm as of late. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), Biogen stock sports a 10-day call/put volume ratio of 2.60, which stands higher than 88% of readings in its annual range. This means calls have been picked up at a quicker-than-usual rate in the last two weeks.

What's more, BIIB options can still be had at a bargain. This is per the stock's Schaeffer's Volatility Index (SVI) of 35%, which stands higher than just 6% of readings from the past 12 months. This means options traders are pricing in relatively low volatility expectations for the equity at the moment. 

On the charts, Biogen stock has trended lower since the Food and Drug Administration (FDA)  approved Aduhelm in June, losing over 30% between its June 7 record high of $468.55 and yesterday's low. The 320-day moving average has remained in place as a layer of support, though, and BIIB boasts a 21.4% year-to-date lead.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI